Logo image of LTH.CA

LITHIUM IONIC CORP (LTH.CA) Stock Fundamental Analysis

TSX-V:LTH - TSX Venture Exchange - CA53680V1076 - Common Stock - Currency: CAD

0.97  -0.04 (-3.96%)

Fundamental Rating

1

Overall LTH gets a fundamental rating of 1 out of 10. We evaluated LTH against 818 industry peers in the Metals & Mining industry. LTH may be in some trouble as it scores bad on both profitability and health. LTH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LTH has reported negative net income.
LTH had a negative operating cash flow in the past year.
LTH.CA Yearly Net Income VS EBIT VS OCF VS FCFLTH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -123.60%, LTH is doing worse than 83.51% of the companies in the same industry.
Industry RankSector Rank
ROA -123.6%
ROE N/A
ROIC N/A
ROA(3y)-192.27%
ROA(5y)N/A
ROE(3y)-294.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LTH.CA Yearly ROA, ROE, ROICLTH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LTH.CA Yearly Profit, Operating, Gross MarginsLTH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for LTH has been increased compared to 1 year ago.
LTH has a worse debt/assets ratio than last year.
LTH.CA Yearly Shares OutstandingLTH.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
LTH.CA Yearly Total Debt VS Total AssetsLTH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -4.82, we must say that LTH is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.82, LTH is doing worse than 69.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.82
ROIC/WACCN/A
WACCN/A
LTH.CA Yearly LT Debt VS Equity VS FCFLTH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M -20M -40M

2.3 Liquidity

LTH has a Current Ratio of 4.22. This indicates that LTH is financially healthy and has no problem in meeting its short term obligations.
LTH has a Current ratio of 4.22. This is in the better half of the industry: LTH outperforms 70.41% of its industry peers.
LTH has a Quick Ratio of 4.22. This indicates that LTH is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 4.22, LTH is doing good in the industry, outperforming 71.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.22
Quick Ratio 4.22
LTH.CA Yearly Current Assets VS Current LiabilitesLTH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.04% over the past year.
EPS 1Y (TTM)40.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 29.85% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y57.89%
EPS Next 2Y31.5%
EPS Next 3Y22.92%
EPS Next 5Y29.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LTH.CA Yearly Revenue VS EstimatesLTH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
LTH.CA Yearly EPS VS EstimatesLTH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LTH.CA Price Earnings VS Forward Price EarningsLTH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LTH.CA Per share dataLTH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2 -0.25

4.3 Compensation for Growth

LTH's earnings are expected to grow with 22.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.5%
EPS Next 3Y22.92%

More info and screens

0

5. Dividend

5.1 Amount

LTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LITHIUM IONIC CORP

TSX-V:LTH (2/21/2025, 7:00:00 PM)

0.97

-0.04 (-3.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-20 2024-11-20/amc
Earnings (Next)N/A N/A
Inst Owners17.74%
Inst Owner ChangeN/A
Ins Owners14.81%
Ins Owner ChangeN/A
Market Cap154.20M
Analysts84.29
Price Target3.95 (307.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-94.17%
Min EPS beat(2)-142.72%
Max EPS beat(2)-45.63%
EPS beat(4)0
Avg EPS beat(4)-71.12%
Min EPS beat(4)-142.72%
Max EPS beat(4)-21.36%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-9.81%
EPS NY rev (3m)-9.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -123.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-192.27%
ROA(5y)N/A
ROE(3y)-294.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 689.81%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.22
Quick Ratio 4.22
Altman-Z -4.82
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.08%
EPS Next Y57.89%
EPS Next 2Y31.5%
EPS Next 3Y22.92%
EPS Next 5Y29.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.16%
EBIT Next 3Y37.92%
EBIT Next 5Y52.19%
FCF growth 1Y-213.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-210.67%
OCF growth 3YN/A
OCF growth 5YN/A